Found 47 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50119621
(CHEMBL3618245)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)C(C)(C)O)cc1F Show InChI InChI=1S/C20H21FN8O2/c1-10-24-16(28-19(22)25-10)15-17(26-12-7-13(21)18(31-4)23-8-12)27-14-6-5-11(9-29(14)15)20(2,3)30/h5-9,26,30H,1-4H3,(H2,22,24,25,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kdelta (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50119621
(CHEMBL3618245)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)C(C)(C)O)cc1F Show InChI InChI=1S/C20H21FN8O2/c1-10-24-16(28-19(22)25-10)15-17(26-12-7-13(21)18(31-4)23-8-12)27-14-6-5-11(9-29(14)15)20(2,3)30/h5-9,26,30H,1-4H3,(H2,22,24,25,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kgamma (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119613
(CHEMBL3618237)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2cccc3[nH]ncc23)nc2ccccn12 Show InChI InChI=1S/C18H15N9/c1-10-21-16(25-18(19)22-10)15-17(24-14-7-2-3-8-27(14)15)23-12-5-4-6-13-11(12)9-20-26-13/h2-9,23H,1H3,(H,20,26)(H2,19,21,22,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119614
(CHEMBL3618238)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCNCC2)cc1F Show InChI InChI=1S/C184H310N50O55/c1-26-30-48-108(206-152(261)109(49-34-39-72-185)207-156(265)114(54-44-77-199-181(193)194)212-170(279)127(82-96(11)12)229-179(288)183(24,88-97(13)14)233-175(284)129(84-107-90-197-92-201-107)225-171(280)128(83-106-46-32-31-33-47-106)224-174(283)133(91-235)228-169(278)126(81-95(9)10)223-173(282)131(86-143(253)254)204-105(23)237)165(274)230-146(100(18)28-3)178(287)220-123(63-71-142(251)252)166(275)231-147(101(19)29-4)177(286)219-122(62-70-141(249)250)163(272)211-110(50-35-40-73-186)153(262)214-117(57-65-135(190)239)159(268)218-120(60-68-139(245)246)161(270)210-111(51-36-41-74-187)154(263)216-119(59-67-138(243)244)160(269)209-112(52-37-42-75-188)155(264)217-121(61-69-140(247)248)162(271)215-118(58-66-137(241)242)151(260)203-102(20)149(258)202-103(21)150(259)205-116(56-64-134(189)238)164(273)226-130(85-136(191)240)172(281)213-115(55-45-78-200-182(195)196)157(266)208-113(53-38-43-76-198-104(22)236)158(267)221-124(79-93(5)6)167(276)222-125(80-94(7)8)168(277)227-132(87-144(255)256)176(285)234-184(25,89-98(15)16)180(289)232-145(148(192)257)99(17)27-2/h31-33,46-47,90,92-103,108-133,145-147,235H,26-30,34-45,48-89,91,185-188H2,1-25H3,(H2,189,238)(H2,190,239)(H2,191,240)(H2,192,257)(H,197,201)(H,198,236)(H,202,258)(H,203,260)(H,204,237)(H,205,259)(H,206,261)(H,207,265)(H,208,266)(H,209,269)(H,210,270)(H,211,272)(H,212,279)(H,213,281)(H,214,262)(H,215,271)(H,216,263)(H,217,264)(H,218,268)(H,219,286)(H,220,287)(H,221,267)(H,222,276)(H,223,282)(H,224,283)(H,225,280)(H,226,273)(H,227,277)(H,228,278)(H,229,288)(H,230,274)(H,231,275)(H,232,289)(H,233,284)(H,234,285)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H4,193,194,199)(H4,195,196,200)/t99?,100?,101?,102-,103-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128?,129-,130-,131-,132-,133-,145?,146-,147-,183+,184+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119619
(CHEMBL3618243)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(=O)N(C)C)cc1F Show InChI InChI=1S/C185H312N50O53/c1-26-30-48-108(205-152(259)109(49-34-39-72-186)206-157(264)114(54-44-77-200-182(194)195)212-171(278)128(83-98(13)14)230-180(287)184(24,89-99(15)16)234-176(283)130(85-107-91-198-93-202-107)227-172(279)129(84-106-46-32-31-33-47-106)226-175(282)134(92-236)229-170(277)127(82-97(11)12)225-174(281)132(87-144(252)253)204-105(23)237)165(272)231-147(102(20)28-3)179(286)220-123(63-71-143(250)251)166(273)232-148(103(21)29-4)178(285)219-122(62-70-142(248)249)164(271)209-110(50-35-40-73-187)154(261)213-116(56-64-135(190)238)160(267)218-120(60-68-140(244)245)162(269)208-111(51-36-41-74-188)155(262)216-119(59-67-139(242)243)161(268)207-112(52-37-42-75-189)156(263)217-121(61-69-141(246)247)163(270)214-117(57-65-136(191)239)159(266)215-118-58-66-138(241)199-76-43-38-53-113(211-173(280)131(86-137(192)240)221-150(257)104(22)203-151(118)258)153(260)210-115(55-45-78-201-183(196)197)158(265)222-124(79-94(5)6)167(274)223-125(80-95(7)8)168(275)224-126(81-96(9)10)169(276)228-133(88-145(254)255)177(284)235-185(25,90-100(17)18)181(288)233-146(149(193)256)101(19)27-2/h31-33,46-47,91,93-104,108-134,146-148,236H,26-30,34-45,48-90,92,186-189H2,1-25H3,(H2,190,238)(H2,191,239)(H2,192,240)(H2,193,256)(H,198,202)(H,199,241)(H,203,258)(H,204,237)(H,205,259)(H,206,264)(H,207,268)(H,208,269)(H,209,271)(H,210,260)(H,211,280)(H,212,278)(H,213,261)(H,214,270)(H,215,266)(H,216,262)(H,217,263)(H,218,267)(H,219,285)(H,220,286)(H,221,257)(H,222,265)(H,223,274)(H,224,275)(H,225,281)(H,226,282)(H,227,279)(H,228,276)(H,229,277)(H,230,287)(H,231,272)(H,232,273)(H,233,288)(H,234,283)(H,235,284)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H4,194,195,200)(H4,196,197,201)/t101?,102?,103?,104-,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118?,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129-,130+,131+,132+,133+,134+,146-,147+,148+,184-,185-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 6.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119617
(CHEMBL3618241)Show SMILES COCCN1CCN(CC1)c1ccc2nc(Nc3cnc(OC)c(F)c3)c(-c3nc(C)nc(N)n3)n2c1 Show InChI InChI=1S/C170H284N44O49/c1-24-28-45-100(188-141(237)101(46-32-37-68-171)189-145(241)106(51-42-73-183-168(179)180)194-158(254)118(77-90(11)12)209-166(262)169(22,83-91(13)14)213-162(258)120(79-99-85-181-86-184-99)205-159(255)119(186-97(21)215)78-98-43-30-29-31-44-98)153(249)210-136(94(18)26-3)165(261)201-114(59-67-133(230)231)154(250)211-137(95(19)27-4)164(260)200-113(58-66-132(228)229)151(247)192-102(47-33-38-69-172)142(238)195-107(52-60-124(175)216)147(243)199-111(56-64-130(224)225)149(245)191-103(48-34-39-70-173)143(239)197-110(55-63-129(222)223)148(244)190-104(49-35-40-71-174)144(240)198-112(57-65-131(226)227)150(246)196-109(54-62-128(220)221)140(236)185-96(20)139(235)187-108-53-61-127(219)182-72-41-36-50-105(193-160(256)121(80-125(176)217)207-161(257)122(81-126(177)218)206-152(108)248)146(242)202-115(74-87(5)6)155(251)203-116(75-88(7)8)156(252)204-117(76-89(9)10)157(253)208-123(82-134(232)233)163(259)214-170(23,84-92(15)16)167(263)212-135(138(178)234)93(17)25-2/h29-31,43-44,85-96,100-123,135-137H,24-28,32-42,45-84,171-174H2,1-23H3,(H2,175,216)(H2,176,217)(H2,177,218)(H2,178,234)(H,181,184)(H,182,219)(H,185,236)(H,186,215)(H,187,235)(H,188,237)(H,189,241)(H,190,244)(H,191,245)(H,192,247)(H,193,256)(H,194,254)(H,195,238)(H,196,246)(H,197,239)(H,198,240)(H,199,243)(H,200,260)(H,201,261)(H,202,242)(H,203,251)(H,204,252)(H,205,255)(H,206,248)(H,207,257)(H,208,253)(H,209,262)(H,210,249)(H,211,250)(H,212,263)(H,213,258)(H,214,259)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,232,233)(H4,179,180,183)/t93?,94?,95?,96-,100-,101-,102-,103-,104-,105-,106-,107-,108?,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119+,120-,121-,122+,123-,135+,136-,137-,169+,170+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 6.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119616
(CHEMBL3618240)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(C)C)cc1F Show InChI InChI=1S/C186H312N52O55/c1-27-31-47-107(206-153(264)108(48-35-39-70-187)207-157(268)112(52-43-74-200-183(195)196)211-171(282)126(80-96(13)14)231-181(292)185(25,87-97(15)16)235-177(288)128(82-106-89-199-91-202-106)227-172(283)127(81-105-45-33-32-34-46-105)226-176(287)133(90-239)230-170(281)125(79-95(11)12)225-175(286)131(85-144(256)257)205-104(24)240)165(276)232-147(100(20)29-3)180(291)220-121(61-69-143(254)255)166(277)233-148(101(21)30-4)179(290)219-120(60-68-142(252)253)164(275)210-109(49-36-40-71-188)154(265)213-114(54-62-134(191)241)160(271)218-118(58-66-140(248)249)162(273)209-110(50-37-41-72-189)155(266)216-117(57-65-139(246)247)161(272)208-111(51-38-42-73-190)156(267)217-119(59-67-141(250)251)163(274)214-115(55-63-135(192)242)159(270)215-116-56-64-137(244)237-238-138(245)84-130(221-151(262)103(23)203-150(261)102(22)204-152(116)263)174(285)228-129(83-136(193)243)173(284)212-113(53-44-75-201-184(197)198)158(269)222-122(76-92(5)6)167(278)223-123(77-93(7)8)168(279)224-124(78-94(9)10)169(280)229-132(86-145(258)259)178(289)236-186(26,88-98(17)18)182(293)234-146(149(194)260)99(19)28-2/h32-34,45-46,89,91-103,107-133,146-148,239H,27-31,35-44,47-88,90,187-190H2,1-26H3,(H2,191,241)(H2,192,242)(H2,193,243)(H2,194,260)(H,199,202)(H,203,261)(H,204,263)(H,205,240)(H,206,264)(H,207,268)(H,208,272)(H,209,273)(H,210,275)(H,211,282)(H,212,284)(H,213,265)(H,214,274)(H,215,270)(H,216,266)(H,217,267)(H,218,271)(H,219,290)(H,220,291)(H,221,262)(H,222,269)(H,223,278)(H,224,279)(H,225,286)(H,226,287)(H,227,283)(H,228,285)(H,229,280)(H,230,281)(H,231,292)(H,232,276)(H,233,277)(H,234,293)(H,235,288)(H,236,289)(H,237,244)(H,238,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H,256,257)(H,258,259)(H4,195,196,200)(H4,197,198,201)/t99?,100?,101?,102-,103+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116-,117+,118+,119+,120+,121+,122+,123+,124+,125+,126+,127?,128+,129+,130+,131+,132+,133+,146+,147+,148+,185-,186-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 6.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119618
(CHEMBL3618242)Show SMILES COc1ccc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(=O)N(C)C)cn1 Show InChI InChI=1S/C183H305N47O55/c1-26-30-47-106(201-151(256)107(48-34-39-70-184)202-155(260)112(53-44-75-196-181(192)193)207-169(274)125(80-96(13)14)225-179(284)182(24,87-97(15)16)229-175(280)127(82-105-89-194-91-197-105)220-170(275)126(81-104-45-32-31-33-46-104)219-174(279)132(90-231)224-168(273)124(79-95(11)12)218-173(278)130(85-143(249)250)199-103(23)232)163(268)226-146(100(20)28-3)178(283)214-120(61-69-142(247)248)164(269)227-147(101(21)29-4)177(282)213-119(60-68-141(245)246)161(266)205-108(49-35-40-71-185)152(257)208-113(54-62-133(188)233)157(262)212-117(58-66-139(241)242)159(264)204-109(50-36-41-72-186)153(258)210-116(57-65-138(239)240)158(263)203-110(51-37-42-73-187)154(259)211-118(59-67-140(243)244)160(265)209-115(56-64-137(237)238)150(255)198-102(22)149(254)200-114-55-63-136(236)195-74-43-38-52-111(206-171(276)128(83-134(189)234)222-172(277)129(84-135(190)235)221-162(114)267)156(261)215-121(76-92(5)6)165(270)216-122(77-93(7)8)166(271)217-123(78-94(9)10)167(272)223-131(86-144(251)252)176(281)230-183(25,88-98(17)18)180(285)228-145(148(191)253)99(19)27-2/h31-33,45-46,89,91-102,106-132,145-147,231H,26-30,34-44,47-88,90,184-187H2,1-25H3,(H2,188,233)(H2,189,234)(H2,190,235)(H2,191,253)(H,194,197)(H,195,236)(H,198,255)(H,199,232)(H,200,254)(H,201,256)(H,202,260)(H,203,263)(H,204,264)(H,205,266)(H,206,276)(H,207,274)(H,208,257)(H,209,265)(H,210,258)(H,211,259)(H,212,262)(H,213,282)(H,214,283)(H,215,261)(H,216,270)(H,217,271)(H,218,278)(H,219,279)(H,220,275)(H,221,267)(H,222,277)(H,223,272)(H,224,273)(H,225,284)(H,226,268)(H,227,269)(H,228,285)(H,229,280)(H,230,281)(H,237,238)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H4,192,193,196)/t99?,100?,101?,102-,106-,107-,108-,109-,110-,111-,112-,113-,114?,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126+,127-,128-,129+,130-,131-,132-,145+,146-,147-,182+,183+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 8.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119621
(CHEMBL3618245)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)C(C)(C)O)cc1F Show InChI InChI=1S/C20H21FN8O2/c1-10-24-16(28-19(22)25-10)15-17(26-12-7-13(21)18(31-4)23-8-12)27-14-6-5-11(9-29(14)15)20(2,3)30/h5-9,26,30H,1-4H3,(H2,22,24,25,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119609
(CHEMBL3618233)Show InChI InChI=1S/C17H15FN8O/c1-9-21-14(25-17(19)22-9)13-15(24-12-5-3-4-6-26(12)13)23-10-7-11(18)16(27-2)20-8-10/h3-8,23H,1-2H3,(H2,19,21,22,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50119621
(CHEMBL3618245)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)C(C)(C)O)cc1F Show InChI InChI=1S/C20H21FN8O2/c1-10-24-16(28-19(22)25-10)15-17(26-12-7-13(21)18(31-4)23-8-12)27-14-6-5-11(9-29(14)15)20(2,3)30/h5-9,26,30H,1-4H3,(H2,22,24,25,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kbeta (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119620
(CHEMBL3618244)Show SMILES COc1ccc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)C(C)(C)O)cn1 Show InChI InChI=1S/C187H315N49O56/c1-27-31-49-110(206-154(263)111(50-35-40-73-188)207-159(268)116(55-45-78-201-184(195)196)213-173(282)130(84-99(13)14)231-182(291)186(25,90-100(15)16)235-178(287)132(86-109-92-199-94-203-109)228-174(283)131(85-108-47-33-32-34-48-108)227-177(286)136(93-237)230-172(281)129(83-98(11)12)226-176(285)134(88-146(256)257)205-107(24)239)167(276)232-149(103(20)29-3)181(290)221-125(64-72-145(254)255)168(277)233-150(104(21)30-4)180(289)220-124(63-71-144(252)253)166(275)210-112(51-36-41-74-189)156(265)214-118(57-65-137(192)240)161(270)218-121(60-68-141(246)247)163(272)209-113(52-37-42-75-190)157(266)216-120(59-67-140(244)245)162(271)208-114(53-38-43-76-191)158(267)217-122(61-69-142(248)249)165(274)219-123(62-70-143(250)251)164(273)215-119(58-66-139(242)243)153(262)204-105(22)152(261)222-133(87-138(193)241)175(284)212-115(54-39-44-77-200-106(23)238)155(264)211-117(56-46-79-202-185(197)198)160(269)223-126(80-95(5)6)169(278)224-127(81-96(7)8)170(279)225-128(82-97(9)10)171(280)229-135(89-147(258)259)179(288)236-187(26,91-101(17)18)183(292)234-148(151(194)260)102(19)28-2/h32-34,47-48,92,94-105,110-136,148-150,237H,27-31,35-46,49-91,93,188-191H2,1-26H3,(H2,192,240)(H2,193,241)(H2,194,260)(H,199,203)(H,200,238)(H,204,262)(H,205,239)(H,206,263)(H,207,268)(H,208,271)(H,209,272)(H,210,275)(H,211,264)(H,212,284)(H,213,282)(H,214,265)(H,215,273)(H,216,266)(H,217,267)(H,218,270)(H,219,274)(H,220,289)(H,221,290)(H,222,261)(H,223,269)(H,224,278)(H,225,279)(H,226,285)(H,227,286)(H,228,283)(H,229,280)(H,230,281)(H,231,291)(H,232,276)(H,233,277)(H,234,292)(H,235,287)(H,236,288)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H,256,257)(H,258,259)(H4,195,196,201)(H4,197,198,202)/t102?,103?,104?,105-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131+,132-,133-,134-,135-,136-,148+,149-,150-,186+,187+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119606
(CHEMBL3618231)Show InChI InChI=1S/C17H16N8O/c1-10-20-15(24-17(18)21-10)14-16(23-12-5-3-4-8-25(12)14)22-11-6-7-13(26-2)19-9-11/h3-9,22H,1-2H3,(H2,18,20,21,24) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 29 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119612
(CHEMBL3618236)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2ccc3cccnc3c2)nc2ccccn12 Show InChI InChI=1S/C183H305N47O55/c1-26-30-47-106(201-151(256)107(48-34-39-70-184)202-155(260)112(53-44-75-196-181(192)193)207-169(274)125(80-96(13)14)225-179(284)182(24,87-97(15)16)229-175(280)127(82-105-89-194-91-197-105)220-170(275)126(81-104-45-32-31-33-46-104)219-174(279)132(90-231)224-168(273)124(79-95(11)12)218-173(278)130(85-143(249)250)199-103(23)232)163(268)226-146(100(20)28-3)178(283)214-120(61-69-142(247)248)164(269)227-147(101(21)29-4)177(282)213-119(60-68-141(245)246)161(266)205-108(49-35-40-71-185)152(257)208-113(54-62-133(188)233)157(262)212-117(58-66-139(241)242)159(264)204-109(50-36-41-72-186)153(258)210-116(57-65-138(239)240)158(263)203-110(51-37-42-73-187)154(259)211-118(59-67-140(243)244)160(265)209-115(56-64-137(237)238)150(255)198-102(22)149(254)200-114-55-63-136(236)195-74-43-38-52-111(206-171(276)128(83-134(189)234)222-172(277)129(84-135(190)235)221-162(114)267)156(261)215-121(76-92(5)6)165(270)216-122(77-93(7)8)166(271)217-123(78-94(9)10)167(272)223-131(86-144(251)252)176(281)230-183(25,88-98(17)18)180(285)228-145(148(191)253)99(19)27-2/h31-33,45-46,89,91-102,106-132,145-147,231H,26-30,34-44,47-88,90,184-187H2,1-25H3,(H2,188,233)(H2,189,234)(H2,190,235)(H2,191,253)(H,194,197)(H,195,236)(H,198,255)(H,199,232)(H,200,254)(H,201,256)(H,202,260)(H,203,263)(H,204,264)(H,205,266)(H,206,276)(H,207,274)(H,208,257)(H,209,265)(H,210,258)(H,211,259)(H,212,262)(H,213,282)(H,214,283)(H,215,261)(H,216,270)(H,217,271)(H,218,278)(H,219,279)(H,220,275)(H,221,267)(H,222,277)(H,223,272)(H,224,273)(H,225,284)(H,226,268)(H,227,269)(H,228,285)(H,229,280)(H,230,281)(H,237,238)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H4,192,193,196)/t99?,100?,101?,102-,106-,107-,108-,109-,110-,111-,112-,113-,114?,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126+,127-,128-,129+,130-,131?,132-,145+,146-,147-,182+,183+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 43 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119615
(CHEMBL3618239)Show SMILES COc1ccc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCNCC2)cn1 Show InChI InChI=1S/C182H305N49O54/c1-25-29-47-106(203-150(257)107(48-33-38-71-183)204-154(261)112(53-43-76-196-179(190)191)209-168(275)125(81-95(11)12)226-177(284)181(23,87-96(13)14)230-173(280)127(83-105-89-194-91-198-105)222-169(276)126(82-104-45-31-30-32-46-104)221-172(279)131(90-232)225-167(274)124(80-94(9)10)220-171(278)129(85-141(249)250)201-103(22)233)163(270)227-144(99(18)27-3)176(283)217-121(62-70-140(247)248)164(271)228-145(100(19)28-4)175(282)216-120(61-69-139(245)246)161(268)208-108(49-34-39-72-184)151(258)211-114(55-63-132(187)234)157(264)215-118(59-67-137(241)242)159(266)207-109(50-35-40-73-185)152(259)213-117(58-66-136(239)240)158(265)206-110(51-36-41-74-186)153(260)214-119(60-68-138(243)244)160(267)212-116(57-65-135(237)238)149(256)200-101(20)147(254)199-102(21)148(255)202-115-56-64-134(236)195-75-42-37-52-111(205-155(262)113(54-44-77-197-180(192)193)210-170(277)128(84-133(188)235)223-162(115)269)156(263)218-122(78-92(5)6)165(272)219-123(79-93(7)8)166(273)224-130(86-142(251)252)174(281)231-182(24,88-97(15)16)178(285)229-143(146(189)253)98(17)26-2/h30-32,45-46,89,91-102,106-131,143-145,232H,25-29,33-44,47-88,90,183-186H2,1-24H3,(H2,187,234)(H2,188,235)(H2,189,253)(H,194,198)(H,195,236)(H,199,254)(H,200,256)(H,201,233)(H,202,255)(H,203,257)(H,204,261)(H,205,262)(H,206,265)(H,207,266)(H,208,268)(H,209,275)(H,210,277)(H,211,258)(H,212,267)(H,213,259)(H,214,260)(H,215,264)(H,216,282)(H,217,283)(H,218,263)(H,219,272)(H,220,278)(H,221,279)(H,222,276)(H,223,269)(H,224,273)(H,225,274)(H,226,284)(H,227,270)(H,228,271)(H,229,285)(H,230,280)(H,231,281)(H,237,238)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H4,190,191,196)(H4,192,193,197)/t98?,99?,100?,101-,102-,106-,107-,108-,109-,110-,111+,112-,113+,114-,115?,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126+,127-,128-,129-,130?,131-,143+,144-,145-,181+,182+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 43 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119611
(CHEMBL3618235)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2ccc3ccncc3c2)nc2ccccn12 Show InChI InChI=1S/C181H305N49O54/c1-27-31-47-105(201-149(256)106(48-35-39-68-182)202-153(260)110(52-43-72-195-178(190)191)206-166(273)123(78-94(13)14)225-176(283)180(25,85-95(15)16)229-172(279)125(80-104-87-194-89-197-104)221-167(274)124(79-103-45-33-32-34-46-103)220-171(278)130(88-231)224-165(272)122(77-93(11)12)219-170(277)128(83-140(248)249)200-102(24)232)160(267)226-143(98(20)29-3)175(282)214-118(60-67-139(246)247)161(268)227-144(99(21)30-4)174(281)213-117(59-66-138(244)245)159(266)205-107(49-36-40-69-183)150(257)208-112(54-61-131(186)233)155(262)212-115(57-64-136(240)241)157(264)204-108(50-37-41-70-184)151(258)210-114(56-63-135(238)239)156(263)203-109(51-38-42-71-185)152(259)211-116(58-65-137(242)243)158(265)209-113(55-62-134(236)237)148(255)199-100(22)146(253)198-101(23)147(254)215-126(81-132(187)234)169(276)222-127(82-133(188)235)168(275)207-111(53-44-73-196-179(192)193)154(261)216-119(74-90(5)6)162(269)217-120(75-91(7)8)163(270)218-121(76-92(9)10)164(271)223-129(84-141(250)251)173(280)230-181(26,86-96(17)18)177(284)228-142(145(189)252)97(19)28-2/h32-34,45-46,87,89-101,105-130,142-144,231H,27-31,35-44,47-86,88,182-185H2,1-26H3,(H2,186,233)(H2,187,234)(H2,188,235)(H2,189,252)(H,194,197)(H,198,253)(H,199,255)(H,200,232)(H,201,256)(H,202,260)(H,203,263)(H,204,264)(H,205,266)(H,206,273)(H,207,275)(H,208,257)(H,209,265)(H,210,258)(H,211,259)(H,212,262)(H,213,281)(H,214,282)(H,215,254)(H,216,261)(H,217,269)(H,218,270)(H,219,277)(H,220,278)(H,221,274)(H,222,276)(H,223,271)(H,224,272)(H,225,283)(H,226,267)(H,227,268)(H,228,284)(H,229,279)(H,230,280)(H,236,237)(H,238,239)(H,240,241)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H4,190,191,195)(H4,192,193,196)/t97?,98?,99?,100-,101-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124+,125-,126-,127-,128-,129-,130-,142+,143-,144-,180?,181?/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 54 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119608
(CHEMBL3618232)Show InChI InChI=1S/C18H18N8O/c1-3-27-14-8-7-12(10-20-14)23-17-15(16-21-11(2)22-18(19)25-16)26-9-5-4-6-13(26)24-17/h4-10,23H,3H2,1-2H3,(H2,19,21,22,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 148 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119610
(CHEMBL3618234)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2ccc3ncccc3c2)nc2ccccn12 Show InChI InChI=1S/C20H16N8/c1-12-23-18(27-20(21)24-12)17-19(26-16-6-2-3-10-28(16)17)25-14-7-8-15-13(11-14)5-4-9-22-15/h2-11,25H,1H3,(H2,21,23,24,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 529 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119612
(CHEMBL3618236)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2ccc3cccnc3c2)nc2ccccn12 Show InChI InChI=1S/C183H305N47O55/c1-26-30-47-106(201-151(256)107(48-34-39-70-184)202-155(260)112(53-44-75-196-181(192)193)207-169(274)125(80-96(13)14)225-179(284)182(24,87-97(15)16)229-175(280)127(82-105-89-194-91-197-105)220-170(275)126(81-104-45-32-31-33-46-104)219-174(279)132(90-231)224-168(273)124(79-95(11)12)218-173(278)130(85-143(249)250)199-103(23)232)163(268)226-146(100(20)28-3)178(283)214-120(61-69-142(247)248)164(269)227-147(101(21)29-4)177(282)213-119(60-68-141(245)246)161(266)205-108(49-35-40-71-185)152(257)208-113(54-62-133(188)233)157(262)212-117(58-66-139(241)242)159(264)204-109(50-36-41-72-186)153(258)210-116(57-65-138(239)240)158(263)203-110(51-37-42-73-187)154(259)211-118(59-67-140(243)244)160(265)209-115(56-64-137(237)238)150(255)198-102(22)149(254)200-114-55-63-136(236)195-74-43-38-52-111(206-171(276)128(83-134(189)234)222-172(277)129(84-135(190)235)221-162(114)267)156(261)215-121(76-92(5)6)165(270)216-122(77-93(7)8)166(271)217-123(78-94(9)10)167(272)223-131(86-144(251)252)176(281)230-183(25,88-98(17)18)180(285)228-145(148(191)253)99(19)27-2/h31-33,45-46,89,91-102,106-132,145-147,231H,26-30,34-44,47-88,90,184-187H2,1-25H3,(H2,188,233)(H2,189,234)(H2,190,235)(H2,191,253)(H,194,197)(H,195,236)(H,198,255)(H,199,232)(H,200,254)(H,201,256)(H,202,260)(H,203,263)(H,204,264)(H,205,266)(H,206,276)(H,207,274)(H,208,257)(H,209,265)(H,210,258)(H,211,259)(H,212,262)(H,213,282)(H,214,283)(H,215,261)(H,216,270)(H,217,271)(H,218,278)(H,219,279)(H,220,275)(H,221,267)(H,222,277)(H,223,272)(H,224,273)(H,225,284)(H,226,268)(H,227,269)(H,228,285)(H,229,280)(H,230,281)(H,237,238)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H4,192,193,196)/t99?,100?,101?,102-,106-,107-,108-,109-,110-,111-,112-,113-,114?,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126+,127-,128-,129+,130-,131?,132-,145+,146-,147-,182+,183+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119621
(CHEMBL3618245)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)C(C)(C)O)cc1F Show InChI InChI=1S/C20H21FN8O2/c1-10-24-16(28-19(22)25-10)15-17(26-12-7-13(21)18(31-4)23-8-12)27-14-6-5-11(9-29(14)15)20(2,3)30/h5-9,26,30H,1-4H3,(H2,22,24,25,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119611
(CHEMBL3618235)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2ccc3ccncc3c2)nc2ccccn12 Show InChI InChI=1S/C181H305N49O54/c1-27-31-47-105(201-149(256)106(48-35-39-68-182)202-153(260)110(52-43-72-195-178(190)191)206-166(273)123(78-94(13)14)225-176(283)180(25,85-95(15)16)229-172(279)125(80-104-87-194-89-197-104)221-167(274)124(79-103-45-33-32-34-46-103)220-171(278)130(88-231)224-165(272)122(77-93(11)12)219-170(277)128(83-140(248)249)200-102(24)232)160(267)226-143(98(20)29-3)175(282)214-118(60-67-139(246)247)161(268)227-144(99(21)30-4)174(281)213-117(59-66-138(244)245)159(266)205-107(49-36-40-69-183)150(257)208-112(54-61-131(186)233)155(262)212-115(57-64-136(240)241)157(264)204-108(50-37-41-70-184)151(258)210-114(56-63-135(238)239)156(263)203-109(51-38-42-71-185)152(259)211-116(58-65-137(242)243)158(265)209-113(55-62-134(236)237)148(255)199-100(22)146(253)198-101(23)147(254)215-126(81-132(187)234)169(276)222-127(82-133(188)235)168(275)207-111(53-44-73-196-179(192)193)154(261)216-119(74-90(5)6)162(269)217-120(75-91(7)8)163(270)218-121(76-92(9)10)164(271)223-129(84-141(250)251)173(280)230-181(26,86-96(17)18)177(284)228-142(145(189)252)97(19)28-2/h32-34,45-46,87,89-101,105-130,142-144,231H,27-31,35-44,47-86,88,182-185H2,1-26H3,(H2,186,233)(H2,187,234)(H2,188,235)(H2,189,252)(H,194,197)(H,198,253)(H,199,255)(H,200,232)(H,201,256)(H,202,260)(H,203,263)(H,204,264)(H,205,266)(H,206,273)(H,207,275)(H,208,257)(H,209,265)(H,210,258)(H,211,259)(H,212,262)(H,213,281)(H,214,282)(H,215,254)(H,216,261)(H,217,269)(H,218,270)(H,219,277)(H,220,278)(H,221,274)(H,222,276)(H,223,271)(H,224,272)(H,225,283)(H,226,267)(H,227,268)(H,228,284)(H,229,279)(H,230,280)(H,236,237)(H,238,239)(H,240,241)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H4,190,191,195)(H4,192,193,196)/t97?,98?,99?,100-,101-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124+,125-,126-,127-,128-,129-,130-,142+,143-,144-,180?,181?/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119613
(CHEMBL3618237)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2cccc3[nH]ncc23)nc2ccccn12 Show InChI InChI=1S/C18H15N9/c1-10-21-16(25-18(19)22-10)15-17(24-14-7-2-3-8-27(14)15)23-12-5-4-6-13-11(12)9-20-26-13/h2-9,23H,1H3,(H,20,26)(H2,19,21,22,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119612
(CHEMBL3618236)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2ccc3cccnc3c2)nc2ccccn12 Show InChI InChI=1S/C183H305N47O55/c1-26-30-47-106(201-151(256)107(48-34-39-70-184)202-155(260)112(53-44-75-196-181(192)193)207-169(274)125(80-96(13)14)225-179(284)182(24,87-97(15)16)229-175(280)127(82-105-89-194-91-197-105)220-170(275)126(81-104-45-32-31-33-46-104)219-174(279)132(90-231)224-168(273)124(79-95(11)12)218-173(278)130(85-143(249)250)199-103(23)232)163(268)226-146(100(20)28-3)178(283)214-120(61-69-142(247)248)164(269)227-147(101(21)29-4)177(282)213-119(60-68-141(245)246)161(266)205-108(49-35-40-71-185)152(257)208-113(54-62-133(188)233)157(262)212-117(58-66-139(241)242)159(264)204-109(50-36-41-72-186)153(258)210-116(57-65-138(239)240)158(263)203-110(51-37-42-73-187)154(259)211-118(59-67-140(243)244)160(265)209-115(56-64-137(237)238)150(255)198-102(22)149(254)200-114-55-63-136(236)195-74-43-38-52-111(206-171(276)128(83-134(189)234)222-172(277)129(84-135(190)235)221-162(114)267)156(261)215-121(76-92(5)6)165(270)216-122(77-93(7)8)166(271)217-123(78-94(9)10)167(272)223-131(86-144(251)252)176(281)230-183(25,88-98(17)18)180(285)228-145(148(191)253)99(19)27-2/h31-33,45-46,89,91-102,106-132,145-147,231H,26-30,34-44,47-88,90,184-187H2,1-25H3,(H2,188,233)(H2,189,234)(H2,190,235)(H2,191,253)(H,194,197)(H,195,236)(H,198,255)(H,199,232)(H,200,254)(H,201,256)(H,202,260)(H,203,263)(H,204,264)(H,205,266)(H,206,276)(H,207,274)(H,208,257)(H,209,265)(H,210,258)(H,211,259)(H,212,262)(H,213,282)(H,214,283)(H,215,261)(H,216,270)(H,217,271)(H,218,278)(H,219,279)(H,220,275)(H,221,267)(H,222,277)(H,223,272)(H,224,273)(H,225,284)(H,226,268)(H,227,269)(H,228,285)(H,229,280)(H,230,281)(H,237,238)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H4,192,193,196)/t99?,100?,101?,102-,106-,107-,108-,109-,110-,111-,112-,113-,114?,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126+,127-,128-,129+,130-,131?,132-,145+,146-,147-,182+,183+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119615
(CHEMBL3618239)Show SMILES COc1ccc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCNCC2)cn1 Show InChI InChI=1S/C182H305N49O54/c1-25-29-47-106(203-150(257)107(48-33-38-71-183)204-154(261)112(53-43-76-196-179(190)191)209-168(275)125(81-95(11)12)226-177(284)181(23,87-96(13)14)230-173(280)127(83-105-89-194-91-198-105)222-169(276)126(82-104-45-31-30-32-46-104)221-172(279)131(90-232)225-167(274)124(80-94(9)10)220-171(278)129(85-141(249)250)201-103(22)233)163(270)227-144(99(18)27-3)176(283)217-121(62-70-140(247)248)164(271)228-145(100(19)28-4)175(282)216-120(61-69-139(245)246)161(268)208-108(49-34-39-72-184)151(258)211-114(55-63-132(187)234)157(264)215-118(59-67-137(241)242)159(266)207-109(50-35-40-73-185)152(259)213-117(58-66-136(239)240)158(265)206-110(51-36-41-74-186)153(260)214-119(60-68-138(243)244)160(267)212-116(57-65-135(237)238)149(256)200-101(20)147(254)199-102(21)148(255)202-115-56-64-134(236)195-75-42-37-52-111(205-155(262)113(54-44-77-197-180(192)193)210-170(277)128(84-133(188)235)223-162(115)269)156(263)218-122(78-92(5)6)165(272)219-123(79-93(7)8)166(273)224-130(86-142(251)252)174(281)231-182(24,88-97(15)16)178(285)229-143(146(189)253)98(17)26-2/h30-32,45-46,89,91-102,106-131,143-145,232H,25-29,33-44,47-88,90,183-186H2,1-24H3,(H2,187,234)(H2,188,235)(H2,189,253)(H,194,198)(H,195,236)(H,199,254)(H,200,256)(H,201,233)(H,202,255)(H,203,257)(H,204,261)(H,205,262)(H,206,265)(H,207,266)(H,208,268)(H,209,275)(H,210,277)(H,211,258)(H,212,267)(H,213,259)(H,214,260)(H,215,264)(H,216,282)(H,217,283)(H,218,263)(H,219,272)(H,220,278)(H,221,279)(H,222,276)(H,223,269)(H,224,273)(H,225,274)(H,226,284)(H,227,270)(H,228,271)(H,229,285)(H,230,280)(H,231,281)(H,237,238)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H4,190,191,196)(H4,192,193,197)/t98?,99?,100?,101-,102-,106-,107-,108-,109-,110-,111+,112-,113+,114-,115?,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126+,127-,128-,129-,130?,131-,143+,144-,145-,181+,182+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119619
(CHEMBL3618243)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(=O)N(C)C)cc1F Show InChI InChI=1S/C185H312N50O53/c1-26-30-48-108(205-152(259)109(49-34-39-72-186)206-157(264)114(54-44-77-200-182(194)195)212-171(278)128(83-98(13)14)230-180(287)184(24,89-99(15)16)234-176(283)130(85-107-91-198-93-202-107)227-172(279)129(84-106-46-32-31-33-47-106)226-175(282)134(92-236)229-170(277)127(82-97(11)12)225-174(281)132(87-144(252)253)204-105(23)237)165(272)231-147(102(20)28-3)179(286)220-123(63-71-143(250)251)166(273)232-148(103(21)29-4)178(285)219-122(62-70-142(248)249)164(271)209-110(50-35-40-73-187)154(261)213-116(56-64-135(190)238)160(267)218-120(60-68-140(244)245)162(269)208-111(51-36-41-74-188)155(262)216-119(59-67-139(242)243)161(268)207-112(52-37-42-75-189)156(263)217-121(61-69-141(246)247)163(270)214-117(57-65-136(191)239)159(266)215-118-58-66-138(241)199-76-43-38-53-113(211-173(280)131(86-137(192)240)221-150(257)104(22)203-151(118)258)153(260)210-115(55-45-78-201-183(196)197)158(265)222-124(79-94(5)6)167(274)223-125(80-95(7)8)168(275)224-126(81-96(9)10)169(276)228-133(88-145(254)255)177(284)235-185(25,90-100(17)18)181(288)233-146(149(193)256)101(19)27-2/h31-33,46-47,91,93-104,108-134,146-148,236H,26-30,34-45,48-90,92,186-189H2,1-25H3,(H2,190,238)(H2,191,239)(H2,192,240)(H2,193,256)(H,198,202)(H,199,241)(H,203,258)(H,204,237)(H,205,259)(H,206,264)(H,207,268)(H,208,269)(H,209,271)(H,210,260)(H,211,280)(H,212,278)(H,213,261)(H,214,270)(H,215,266)(H,216,262)(H,217,263)(H,218,267)(H,219,285)(H,220,286)(H,221,257)(H,222,265)(H,223,274)(H,224,275)(H,225,281)(H,226,282)(H,227,279)(H,228,276)(H,229,277)(H,230,287)(H,231,272)(H,232,273)(H,233,288)(H,234,283)(H,235,284)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H4,194,195,200)(H4,196,197,201)/t101?,102?,103?,104-,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118?,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129-,130+,131+,132+,133+,134+,146-,147+,148+,184-,185-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119617
(CHEMBL3618241)Show SMILES COCCN1CCN(CC1)c1ccc2nc(Nc3cnc(OC)c(F)c3)c(-c3nc(C)nc(N)n3)n2c1 Show InChI InChI=1S/C170H284N44O49/c1-24-28-45-100(188-141(237)101(46-32-37-68-171)189-145(241)106(51-42-73-183-168(179)180)194-158(254)118(77-90(11)12)209-166(262)169(22,83-91(13)14)213-162(258)120(79-99-85-181-86-184-99)205-159(255)119(186-97(21)215)78-98-43-30-29-31-44-98)153(249)210-136(94(18)26-3)165(261)201-114(59-67-133(230)231)154(250)211-137(95(19)27-4)164(260)200-113(58-66-132(228)229)151(247)192-102(47-33-38-69-172)142(238)195-107(52-60-124(175)216)147(243)199-111(56-64-130(224)225)149(245)191-103(48-34-39-70-173)143(239)197-110(55-63-129(222)223)148(244)190-104(49-35-40-71-174)144(240)198-112(57-65-131(226)227)150(246)196-109(54-62-128(220)221)140(236)185-96(20)139(235)187-108-53-61-127(219)182-72-41-36-50-105(193-160(256)121(80-125(176)217)207-161(257)122(81-126(177)218)206-152(108)248)146(242)202-115(74-87(5)6)155(251)203-116(75-88(7)8)156(252)204-117(76-89(9)10)157(253)208-123(82-134(232)233)163(259)214-170(23,84-92(15)16)167(263)212-135(138(178)234)93(17)25-2/h29-31,43-44,85-96,100-123,135-137H,24-28,32-42,45-84,171-174H2,1-23H3,(H2,175,216)(H2,176,217)(H2,177,218)(H2,178,234)(H,181,184)(H,182,219)(H,185,236)(H,186,215)(H,187,235)(H,188,237)(H,189,241)(H,190,244)(H,191,245)(H,192,247)(H,193,256)(H,194,254)(H,195,238)(H,196,246)(H,197,239)(H,198,240)(H,199,243)(H,200,260)(H,201,261)(H,202,242)(H,203,251)(H,204,252)(H,205,255)(H,206,248)(H,207,257)(H,208,253)(H,209,262)(H,210,249)(H,211,250)(H,212,263)(H,213,258)(H,214,259)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,232,233)(H4,179,180,183)/t93?,94?,95?,96-,100-,101-,102-,103-,104-,105-,106-,107-,108?,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119+,120-,121-,122+,123-,135+,136-,137-,169+,170+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119613
(CHEMBL3618237)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2cccc3[nH]ncc23)nc2ccccn12 Show InChI InChI=1S/C18H15N9/c1-10-21-16(25-18(19)22-10)15-17(24-14-7-2-3-8-27(14)15)23-12-5-4-6-13-11(12)9-20-26-13/h2-9,23H,1H3,(H,20,26)(H2,19,21,22,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119618
(CHEMBL3618242)Show SMILES COc1ccc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(=O)N(C)C)cn1 Show InChI InChI=1S/C183H305N47O55/c1-26-30-47-106(201-151(256)107(48-34-39-70-184)202-155(260)112(53-44-75-196-181(192)193)207-169(274)125(80-96(13)14)225-179(284)182(24,87-97(15)16)229-175(280)127(82-105-89-194-91-197-105)220-170(275)126(81-104-45-32-31-33-46-104)219-174(279)132(90-231)224-168(273)124(79-95(11)12)218-173(278)130(85-143(249)250)199-103(23)232)163(268)226-146(100(20)28-3)178(283)214-120(61-69-142(247)248)164(269)227-147(101(21)29-4)177(282)213-119(60-68-141(245)246)161(266)205-108(49-35-40-71-185)152(257)208-113(54-62-133(188)233)157(262)212-117(58-66-139(241)242)159(264)204-109(50-36-41-72-186)153(258)210-116(57-65-138(239)240)158(263)203-110(51-37-42-73-187)154(259)211-118(59-67-140(243)244)160(265)209-115(56-64-137(237)238)150(255)198-102(22)149(254)200-114-55-63-136(236)195-74-43-38-52-111(206-171(276)128(83-134(189)234)222-172(277)129(84-135(190)235)221-162(114)267)156(261)215-121(76-92(5)6)165(270)216-122(77-93(7)8)166(271)217-123(78-94(9)10)167(272)223-131(86-144(251)252)176(281)230-183(25,88-98(17)18)180(285)228-145(148(191)253)99(19)27-2/h31-33,45-46,89,91-102,106-132,145-147,231H,26-30,34-44,47-88,90,184-187H2,1-25H3,(H2,188,233)(H2,189,234)(H2,190,235)(H2,191,253)(H,194,197)(H,195,236)(H,198,255)(H,199,232)(H,200,254)(H,201,256)(H,202,260)(H,203,263)(H,204,264)(H,205,266)(H,206,276)(H,207,274)(H,208,257)(H,209,265)(H,210,258)(H,211,259)(H,212,262)(H,213,282)(H,214,283)(H,215,261)(H,216,270)(H,217,271)(H,218,278)(H,219,279)(H,220,275)(H,221,267)(H,222,277)(H,223,272)(H,224,273)(H,225,284)(H,226,268)(H,227,269)(H,228,285)(H,229,280)(H,230,281)(H,237,238)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H4,192,193,196)/t99?,100?,101?,102-,106-,107-,108-,109-,110-,111-,112-,113-,114?,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126+,127-,128-,129+,130-,131-,132-,145+,146-,147-,182+,183+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119618
(CHEMBL3618242)Show SMILES COc1ccc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(=O)N(C)C)cn1 Show InChI InChI=1S/C183H305N47O55/c1-26-30-47-106(201-151(256)107(48-34-39-70-184)202-155(260)112(53-44-75-196-181(192)193)207-169(274)125(80-96(13)14)225-179(284)182(24,87-97(15)16)229-175(280)127(82-105-89-194-91-197-105)220-170(275)126(81-104-45-32-31-33-46-104)219-174(279)132(90-231)224-168(273)124(79-95(11)12)218-173(278)130(85-143(249)250)199-103(23)232)163(268)226-146(100(20)28-3)178(283)214-120(61-69-142(247)248)164(269)227-147(101(21)29-4)177(282)213-119(60-68-141(245)246)161(266)205-108(49-35-40-71-185)152(257)208-113(54-62-133(188)233)157(262)212-117(58-66-139(241)242)159(264)204-109(50-36-41-72-186)153(258)210-116(57-65-138(239)240)158(263)203-110(51-37-42-73-187)154(259)211-118(59-67-140(243)244)160(265)209-115(56-64-137(237)238)150(255)198-102(22)149(254)200-114-55-63-136(236)195-74-43-38-52-111(206-171(276)128(83-134(189)234)222-172(277)129(84-135(190)235)221-162(114)267)156(261)215-121(76-92(5)6)165(270)216-122(77-93(7)8)166(271)217-123(78-94(9)10)167(272)223-131(86-144(251)252)176(281)230-183(25,88-98(17)18)180(285)228-145(148(191)253)99(19)27-2/h31-33,45-46,89,91-102,106-132,145-147,231H,26-30,34-44,47-88,90,184-187H2,1-25H3,(H2,188,233)(H2,189,234)(H2,190,235)(H2,191,253)(H,194,197)(H,195,236)(H,198,255)(H,199,232)(H,200,254)(H,201,256)(H,202,260)(H,203,263)(H,204,264)(H,205,266)(H,206,276)(H,207,274)(H,208,257)(H,209,265)(H,210,258)(H,211,259)(H,212,262)(H,213,282)(H,214,283)(H,215,261)(H,216,270)(H,217,271)(H,218,278)(H,219,279)(H,220,275)(H,221,267)(H,222,277)(H,223,272)(H,224,273)(H,225,284)(H,226,268)(H,227,269)(H,228,285)(H,229,280)(H,230,281)(H,237,238)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H4,192,193,196)/t99?,100?,101?,102-,106-,107-,108-,109-,110-,111-,112-,113-,114?,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126+,127-,128-,129+,130-,131-,132-,145+,146-,147-,182+,183+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119620
(CHEMBL3618244)Show SMILES COc1ccc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)C(C)(C)O)cn1 Show InChI InChI=1S/C187H315N49O56/c1-27-31-49-110(206-154(263)111(50-35-40-73-188)207-159(268)116(55-45-78-201-184(195)196)213-173(282)130(84-99(13)14)231-182(291)186(25,90-100(15)16)235-178(287)132(86-109-92-199-94-203-109)228-174(283)131(85-108-47-33-32-34-48-108)227-177(286)136(93-237)230-172(281)129(83-98(11)12)226-176(285)134(88-146(256)257)205-107(24)239)167(276)232-149(103(20)29-3)181(290)221-125(64-72-145(254)255)168(277)233-150(104(21)30-4)180(289)220-124(63-71-144(252)253)166(275)210-112(51-36-41-74-189)156(265)214-118(57-65-137(192)240)161(270)218-121(60-68-141(246)247)163(272)209-113(52-37-42-75-190)157(266)216-120(59-67-140(244)245)162(271)208-114(53-38-43-76-191)158(267)217-122(61-69-142(248)249)165(274)219-123(62-70-143(250)251)164(273)215-119(58-66-139(242)243)153(262)204-105(22)152(261)222-133(87-138(193)241)175(284)212-115(54-39-44-77-200-106(23)238)155(264)211-117(56-46-79-202-185(197)198)160(269)223-126(80-95(5)6)169(278)224-127(81-96(7)8)170(279)225-128(82-97(9)10)171(280)229-135(89-147(258)259)179(288)236-187(26,91-101(17)18)183(292)234-148(151(194)260)102(19)28-2/h32-34,47-48,92,94-105,110-136,148-150,237H,27-31,35-46,49-91,93,188-191H2,1-26H3,(H2,192,240)(H2,193,241)(H2,194,260)(H,199,203)(H,200,238)(H,204,262)(H,205,239)(H,206,263)(H,207,268)(H,208,271)(H,209,272)(H,210,275)(H,211,264)(H,212,284)(H,213,282)(H,214,265)(H,215,273)(H,216,266)(H,217,267)(H,218,270)(H,219,274)(H,220,289)(H,221,290)(H,222,261)(H,223,269)(H,224,278)(H,225,279)(H,226,285)(H,227,286)(H,228,283)(H,229,280)(H,230,281)(H,231,291)(H,232,276)(H,233,277)(H,234,292)(H,235,287)(H,236,288)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H,256,257)(H,258,259)(H4,195,196,201)(H4,197,198,202)/t102?,103?,104?,105-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131+,132-,133-,134-,135-,136-,148+,149-,150-,186+,187+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119606
(CHEMBL3618231)Show InChI InChI=1S/C17H16N8O/c1-10-20-15(24-17(18)21-10)14-16(23-12-5-3-4-8-25(12)14)22-11-6-7-13(26-2)19-9-11/h3-9,22H,1-2H3,(H2,18,20,21,24) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119606
(CHEMBL3618231)Show InChI InChI=1S/C17H16N8O/c1-10-20-15(24-17(18)21-10)14-16(23-12-5-3-4-8-25(12)14)22-11-6-7-13(26-2)19-9-11/h3-9,22H,1-2H3,(H2,18,20,21,24) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119614
(CHEMBL3618238)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCNCC2)cc1F Show InChI InChI=1S/C184H310N50O55/c1-26-30-48-108(206-152(261)109(49-34-39-72-185)207-156(265)114(54-44-77-199-181(193)194)212-170(279)127(82-96(11)12)229-179(288)183(24,88-97(13)14)233-175(284)129(84-107-90-197-92-201-107)225-171(280)128(83-106-46-32-31-33-47-106)224-174(283)133(91-235)228-169(278)126(81-95(9)10)223-173(282)131(86-143(253)254)204-105(23)237)165(274)230-146(100(18)28-3)178(287)220-123(63-71-142(251)252)166(275)231-147(101(19)29-4)177(286)219-122(62-70-141(249)250)163(272)211-110(50-35-40-73-186)153(262)214-117(57-65-135(190)239)159(268)218-120(60-68-139(245)246)161(270)210-111(51-36-41-74-187)154(263)216-119(59-67-138(243)244)160(269)209-112(52-37-42-75-188)155(264)217-121(61-69-140(247)248)162(271)215-118(58-66-137(241)242)151(260)203-102(20)149(258)202-103(21)150(259)205-116(56-64-134(189)238)164(273)226-130(85-136(191)240)172(281)213-115(55-45-78-200-182(195)196)157(266)208-113(53-38-43-76-198-104(22)236)158(267)221-124(79-93(5)6)167(276)222-125(80-94(7)8)168(277)227-132(87-144(255)256)176(285)234-184(25,89-98(15)16)180(289)232-145(148(192)257)99(17)27-2/h31-33,46-47,90,92-103,108-133,145-147,235H,26-30,34-45,48-89,91,185-188H2,1-25H3,(H2,189,238)(H2,190,239)(H2,191,240)(H2,192,257)(H,197,201)(H,198,236)(H,202,258)(H,203,260)(H,204,237)(H,205,259)(H,206,261)(H,207,265)(H,208,266)(H,209,269)(H,210,270)(H,211,272)(H,212,279)(H,213,281)(H,214,262)(H,215,271)(H,216,263)(H,217,264)(H,218,268)(H,219,286)(H,220,287)(H,221,267)(H,222,276)(H,223,282)(H,224,283)(H,225,280)(H,226,273)(H,227,277)(H,228,278)(H,229,288)(H,230,274)(H,231,275)(H,232,289)(H,233,284)(H,234,285)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H4,193,194,199)(H4,195,196,200)/t99?,100?,101?,102-,103-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128?,129-,130-,131-,132-,133-,145?,146-,147-,183+,184+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119620
(CHEMBL3618244)Show SMILES COc1ccc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)C(C)(C)O)cn1 Show InChI InChI=1S/C187H315N49O56/c1-27-31-49-110(206-154(263)111(50-35-40-73-188)207-159(268)116(55-45-78-201-184(195)196)213-173(282)130(84-99(13)14)231-182(291)186(25,90-100(15)16)235-178(287)132(86-109-92-199-94-203-109)228-174(283)131(85-108-47-33-32-34-48-108)227-177(286)136(93-237)230-172(281)129(83-98(11)12)226-176(285)134(88-146(256)257)205-107(24)239)167(276)232-149(103(20)29-3)181(290)221-125(64-72-145(254)255)168(277)233-150(104(21)30-4)180(289)220-124(63-71-144(252)253)166(275)210-112(51-36-41-74-189)156(265)214-118(57-65-137(192)240)161(270)218-121(60-68-141(246)247)163(272)209-113(52-37-42-75-190)157(266)216-120(59-67-140(244)245)162(271)208-114(53-38-43-76-191)158(267)217-122(61-69-142(248)249)165(274)219-123(62-70-143(250)251)164(273)215-119(58-66-139(242)243)153(262)204-105(22)152(261)222-133(87-138(193)241)175(284)212-115(54-39-44-77-200-106(23)238)155(264)211-117(56-46-79-202-185(197)198)160(269)223-126(80-95(5)6)169(278)224-127(81-96(7)8)170(279)225-128(82-97(9)10)171(280)229-135(89-147(258)259)179(288)236-187(26,91-101(17)18)183(292)234-148(151(194)260)102(19)28-2/h32-34,47-48,92,94-105,110-136,148-150,237H,27-31,35-46,49-91,93,188-191H2,1-26H3,(H2,192,240)(H2,193,241)(H2,194,260)(H,199,203)(H,200,238)(H,204,262)(H,205,239)(H,206,263)(H,207,268)(H,208,271)(H,209,272)(H,210,275)(H,211,264)(H,212,284)(H,213,282)(H,214,265)(H,215,273)(H,216,266)(H,217,267)(H,218,270)(H,219,274)(H,220,289)(H,221,290)(H,222,261)(H,223,269)(H,224,278)(H,225,279)(H,226,285)(H,227,286)(H,228,283)(H,229,280)(H,230,281)(H,231,291)(H,232,276)(H,233,277)(H,234,292)(H,235,287)(H,236,288)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H,256,257)(H,258,259)(H4,195,196,201)(H4,197,198,202)/t102?,103?,104?,105-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131+,132-,133-,134-,135-,136-,148+,149-,150-,186+,187+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119608
(CHEMBL3618232)Show InChI InChI=1S/C18H18N8O/c1-3-27-14-8-7-12(10-20-14)23-17-15(16-21-11(2)22-18(19)25-16)26-9-5-4-6-13(26)24-17/h4-10,23H,3H2,1-2H3,(H2,19,21,22,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 57 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119614
(CHEMBL3618238)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCNCC2)cc1F Show InChI InChI=1S/C184H310N50O55/c1-26-30-48-108(206-152(261)109(49-34-39-72-185)207-156(265)114(54-44-77-199-181(193)194)212-170(279)127(82-96(11)12)229-179(288)183(24,88-97(13)14)233-175(284)129(84-107-90-197-92-201-107)225-171(280)128(83-106-46-32-31-33-47-106)224-174(283)133(91-235)228-169(278)126(81-95(9)10)223-173(282)131(86-143(253)254)204-105(23)237)165(274)230-146(100(18)28-3)178(287)220-123(63-71-142(251)252)166(275)231-147(101(19)29-4)177(286)219-122(62-70-141(249)250)163(272)211-110(50-35-40-73-186)153(262)214-117(57-65-135(190)239)159(268)218-120(60-68-139(245)246)161(270)210-111(51-36-41-74-187)154(263)216-119(59-67-138(243)244)160(269)209-112(52-37-42-75-188)155(264)217-121(61-69-140(247)248)162(271)215-118(58-66-137(241)242)151(260)203-102(20)149(258)202-103(21)150(259)205-116(56-64-134(189)238)164(273)226-130(85-136(191)240)172(281)213-115(55-45-78-200-182(195)196)157(266)208-113(53-38-43-76-198-104(22)236)158(267)221-124(79-93(5)6)167(276)222-125(80-94(7)8)168(277)227-132(87-144(255)256)176(285)234-184(25,89-98(15)16)180(289)232-145(148(192)257)99(17)27-2/h31-33,46-47,90,92-103,108-133,145-147,235H,26-30,34-45,48-89,91,185-188H2,1-25H3,(H2,189,238)(H2,190,239)(H2,191,240)(H2,192,257)(H,197,201)(H,198,236)(H,202,258)(H,203,260)(H,204,237)(H,205,259)(H,206,261)(H,207,265)(H,208,266)(H,209,269)(H,210,270)(H,211,272)(H,212,279)(H,213,281)(H,214,262)(H,215,271)(H,216,263)(H,217,264)(H,218,268)(H,219,286)(H,220,287)(H,221,267)(H,222,276)(H,223,282)(H,224,283)(H,225,280)(H,226,273)(H,227,277)(H,228,278)(H,229,288)(H,230,274)(H,231,275)(H,232,289)(H,233,284)(H,234,285)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H4,193,194,199)(H4,195,196,200)/t99?,100?,101?,102-,103-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128?,129-,130-,131-,132-,133-,145?,146-,147-,183+,184+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119615
(CHEMBL3618239)Show SMILES COc1ccc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCNCC2)cn1 Show InChI InChI=1S/C182H305N49O54/c1-25-29-47-106(203-150(257)107(48-33-38-71-183)204-154(261)112(53-43-76-196-179(190)191)209-168(275)125(81-95(11)12)226-177(284)181(23,87-96(13)14)230-173(280)127(83-105-89-194-91-198-105)222-169(276)126(82-104-45-31-30-32-46-104)221-172(279)131(90-232)225-167(274)124(80-94(9)10)220-171(278)129(85-141(249)250)201-103(22)233)163(270)227-144(99(18)27-3)176(283)217-121(62-70-140(247)248)164(271)228-145(100(19)28-4)175(282)216-120(61-69-139(245)246)161(268)208-108(49-34-39-72-184)151(258)211-114(55-63-132(187)234)157(264)215-118(59-67-137(241)242)159(266)207-109(50-35-40-73-185)152(259)213-117(58-66-136(239)240)158(265)206-110(51-36-41-74-186)153(260)214-119(60-68-138(243)244)160(267)212-116(57-65-135(237)238)149(256)200-101(20)147(254)199-102(21)148(255)202-115-56-64-134(236)195-75-42-37-52-111(205-155(262)113(54-44-77-197-180(192)193)210-170(277)128(84-133(188)235)223-162(115)269)156(263)218-122(78-92(5)6)165(272)219-123(79-93(7)8)166(273)224-130(86-142(251)252)174(281)231-182(24,88-97(15)16)178(285)229-143(146(189)253)98(17)26-2/h30-32,45-46,89,91-102,106-131,143-145,232H,25-29,33-44,47-88,90,183-186H2,1-24H3,(H2,187,234)(H2,188,235)(H2,189,253)(H,194,198)(H,195,236)(H,199,254)(H,200,256)(H,201,233)(H,202,255)(H,203,257)(H,204,261)(H,205,262)(H,206,265)(H,207,266)(H,208,268)(H,209,275)(H,210,277)(H,211,258)(H,212,267)(H,213,259)(H,214,260)(H,215,264)(H,216,282)(H,217,283)(H,218,263)(H,219,272)(H,220,278)(H,221,279)(H,222,276)(H,223,269)(H,224,273)(H,225,274)(H,226,284)(H,227,270)(H,228,271)(H,229,285)(H,230,280)(H,231,281)(H,237,238)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H4,190,191,196)(H4,192,193,197)/t98?,99?,100?,101-,102-,106-,107-,108-,109-,110-,111+,112-,113+,114-,115?,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126+,127-,128-,129-,130?,131-,143+,144-,145-,181+,182+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 69 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119609
(CHEMBL3618233)Show InChI InChI=1S/C17H15FN8O/c1-9-21-14(25-17(19)22-9)13-15(24-12-5-3-4-6-26(12)13)23-10-7-11(18)16(27-2)20-8-10/h3-8,23H,1-2H3,(H2,19,21,22,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 86 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119617
(CHEMBL3618241)Show SMILES COCCN1CCN(CC1)c1ccc2nc(Nc3cnc(OC)c(F)c3)c(-c3nc(C)nc(N)n3)n2c1 Show InChI InChI=1S/C170H284N44O49/c1-24-28-45-100(188-141(237)101(46-32-37-68-171)189-145(241)106(51-42-73-183-168(179)180)194-158(254)118(77-90(11)12)209-166(262)169(22,83-91(13)14)213-162(258)120(79-99-85-181-86-184-99)205-159(255)119(186-97(21)215)78-98-43-30-29-31-44-98)153(249)210-136(94(18)26-3)165(261)201-114(59-67-133(230)231)154(250)211-137(95(19)27-4)164(260)200-113(58-66-132(228)229)151(247)192-102(47-33-38-69-172)142(238)195-107(52-60-124(175)216)147(243)199-111(56-64-130(224)225)149(245)191-103(48-34-39-70-173)143(239)197-110(55-63-129(222)223)148(244)190-104(49-35-40-71-174)144(240)198-112(57-65-131(226)227)150(246)196-109(54-62-128(220)221)140(236)185-96(20)139(235)187-108-53-61-127(219)182-72-41-36-50-105(193-160(256)121(80-125(176)217)207-161(257)122(81-126(177)218)206-152(108)248)146(242)202-115(74-87(5)6)155(251)203-116(75-88(7)8)156(252)204-117(76-89(9)10)157(253)208-123(82-134(232)233)163(259)214-170(23,84-92(15)16)167(263)212-135(138(178)234)93(17)25-2/h29-31,43-44,85-96,100-123,135-137H,24-28,32-42,45-84,171-174H2,1-23H3,(H2,175,216)(H2,176,217)(H2,177,218)(H2,178,234)(H,181,184)(H,182,219)(H,185,236)(H,186,215)(H,187,235)(H,188,237)(H,189,241)(H,190,244)(H,191,245)(H,192,247)(H,193,256)(H,194,254)(H,195,238)(H,196,246)(H,197,239)(H,198,240)(H,199,243)(H,200,260)(H,201,261)(H,202,242)(H,203,251)(H,204,252)(H,205,255)(H,206,248)(H,207,257)(H,208,253)(H,209,262)(H,210,249)(H,211,250)(H,212,263)(H,213,258)(H,214,259)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,232,233)(H4,179,180,183)/t93?,94?,95?,96-,100-,101-,102-,103-,104-,105-,106-,107-,108?,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119+,120-,121-,122+,123-,135+,136-,137-,169+,170+/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 121 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119619
(CHEMBL3618243)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(=O)N(C)C)cc1F Show InChI InChI=1S/C185H312N50O53/c1-26-30-48-108(205-152(259)109(49-34-39-72-186)206-157(264)114(54-44-77-200-182(194)195)212-171(278)128(83-98(13)14)230-180(287)184(24,89-99(15)16)234-176(283)130(85-107-91-198-93-202-107)227-172(279)129(84-106-46-32-31-33-47-106)226-175(282)134(92-236)229-170(277)127(82-97(11)12)225-174(281)132(87-144(252)253)204-105(23)237)165(272)231-147(102(20)28-3)179(286)220-123(63-71-143(250)251)166(273)232-148(103(21)29-4)178(285)219-122(62-70-142(248)249)164(271)209-110(50-35-40-73-187)154(261)213-116(56-64-135(190)238)160(267)218-120(60-68-140(244)245)162(269)208-111(51-36-41-74-188)155(262)216-119(59-67-139(242)243)161(268)207-112(52-37-42-75-189)156(263)217-121(61-69-141(246)247)163(270)214-117(57-65-136(191)239)159(266)215-118-58-66-138(241)199-76-43-38-53-113(211-173(280)131(86-137(192)240)221-150(257)104(22)203-151(118)258)153(260)210-115(55-45-78-201-183(196)197)158(265)222-124(79-94(5)6)167(274)223-125(80-95(7)8)168(275)224-126(81-96(9)10)169(276)228-133(88-145(254)255)177(284)235-185(25,90-100(17)18)181(288)233-146(149(193)256)101(19)27-2/h31-33,46-47,91,93-104,108-134,146-148,236H,26-30,34-45,48-90,92,186-189H2,1-25H3,(H2,190,238)(H2,191,239)(H2,192,240)(H2,193,256)(H,198,202)(H,199,241)(H,203,258)(H,204,237)(H,205,259)(H,206,264)(H,207,268)(H,208,269)(H,209,271)(H,210,260)(H,211,280)(H,212,278)(H,213,261)(H,214,270)(H,215,266)(H,216,262)(H,217,263)(H,218,267)(H,219,285)(H,220,286)(H,221,257)(H,222,265)(H,223,274)(H,224,275)(H,225,281)(H,226,282)(H,227,279)(H,228,276)(H,229,277)(H,230,287)(H,231,272)(H,232,273)(H,233,288)(H,234,283)(H,235,284)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H4,194,195,200)(H4,196,197,201)/t101?,102?,103?,104-,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118?,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129-,130+,131+,132+,133+,134+,146-,147+,148+,184-,185-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 157 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119609
(CHEMBL3618233)Show InChI InChI=1S/C17H15FN8O/c1-9-21-14(25-17(19)22-9)13-15(24-12-5-3-4-6-26(12)13)23-10-7-11(18)16(27-2)20-8-10/h3-8,23H,1-2H3,(H2,19,21,22,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 198 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119621
(CHEMBL3618245)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)C(C)(C)O)cc1F Show InChI InChI=1S/C20H21FN8O2/c1-10-24-16(28-19(22)25-10)15-17(26-12-7-13(21)18(31-4)23-8-12)27-14-6-5-11(9-29(14)15)20(2,3)30/h5-9,26,30H,1-4H3,(H2,22,24,25,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 206 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119608
(CHEMBL3618232)Show InChI InChI=1S/C18H18N8O/c1-3-27-14-8-7-12(10-20-14)23-17-15(16-21-11(2)22-18(19)25-16)26-9-5-4-6-13(26)24-17/h4-10,23H,3H2,1-2H3,(H2,19,21,22,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 229 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119610
(CHEMBL3618234)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2ccc3ncccc3c2)nc2ccccn12 Show InChI InChI=1S/C20H16N8/c1-12-23-18(27-20(21)24-12)17-19(26-16-6-2-3-10-28(16)17)25-14-7-8-15-13(11-14)5-4-9-22-15/h2-11,25H,1H3,(H2,21,23,24,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 277 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119616
(CHEMBL3618240)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(C)C)cc1F Show InChI InChI=1S/C186H312N52O55/c1-27-31-47-107(206-153(264)108(48-35-39-70-187)207-157(268)112(52-43-74-200-183(195)196)211-171(282)126(80-96(13)14)231-181(292)185(25,87-97(15)16)235-177(288)128(82-106-89-199-91-202-106)227-172(283)127(81-105-45-33-32-34-46-105)226-176(287)133(90-239)230-170(281)125(79-95(11)12)225-175(286)131(85-144(256)257)205-104(24)240)165(276)232-147(100(20)29-3)180(291)220-121(61-69-143(254)255)166(277)233-148(101(21)30-4)179(290)219-120(60-68-142(252)253)164(275)210-109(49-36-40-71-188)154(265)213-114(54-62-134(191)241)160(271)218-118(58-66-140(248)249)162(273)209-110(50-37-41-72-189)155(266)216-117(57-65-139(246)247)161(272)208-111(51-38-42-73-190)156(267)217-119(59-67-141(250)251)163(274)214-115(55-63-135(192)242)159(270)215-116-56-64-137(244)237-238-138(245)84-130(221-151(262)103(23)203-150(261)102(22)204-152(116)263)174(285)228-129(83-136(193)243)173(284)212-113(53-44-75-201-184(197)198)158(269)222-122(76-92(5)6)167(278)223-123(77-93(7)8)168(279)224-124(78-94(9)10)169(280)229-132(86-145(258)259)178(289)236-186(26,88-98(17)18)182(293)234-146(149(194)260)99(19)28-2/h32-34,45-46,89,91-103,107-133,146-148,239H,27-31,35-44,47-88,90,187-190H2,1-26H3,(H2,191,241)(H2,192,242)(H2,193,243)(H2,194,260)(H,199,202)(H,203,261)(H,204,263)(H,205,240)(H,206,264)(H,207,268)(H,208,272)(H,209,273)(H,210,275)(H,211,282)(H,212,284)(H,213,265)(H,214,274)(H,215,270)(H,216,266)(H,217,267)(H,218,271)(H,219,290)(H,220,291)(H,221,262)(H,222,269)(H,223,278)(H,224,279)(H,225,286)(H,226,287)(H,227,283)(H,228,285)(H,229,280)(H,230,281)(H,231,292)(H,232,276)(H,233,277)(H,234,293)(H,235,288)(H,236,289)(H,237,244)(H,238,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H,256,257)(H,258,259)(H4,195,196,200)(H4,197,198,201)/t99?,100?,101?,102-,103+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116-,117+,118+,119+,120+,121+,122+,123+,124+,125+,126+,127?,128+,129+,130+,131+,132+,133+,146+,147+,148+,185-,186-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 294 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50119616
(CHEMBL3618240)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(C)C)cc1F Show InChI InChI=1S/C186H312N52O55/c1-27-31-47-107(206-153(264)108(48-35-39-70-187)207-157(268)112(52-43-74-200-183(195)196)211-171(282)126(80-96(13)14)231-181(292)185(25,87-97(15)16)235-177(288)128(82-106-89-199-91-202-106)227-172(283)127(81-105-45-33-32-34-46-105)226-176(287)133(90-239)230-170(281)125(79-95(11)12)225-175(286)131(85-144(256)257)205-104(24)240)165(276)232-147(100(20)29-3)180(291)220-121(61-69-143(254)255)166(277)233-148(101(21)30-4)179(290)219-120(60-68-142(252)253)164(275)210-109(49-36-40-71-188)154(265)213-114(54-62-134(191)241)160(271)218-118(58-66-140(248)249)162(273)209-110(50-37-41-72-189)155(266)216-117(57-65-139(246)247)161(272)208-111(51-38-42-73-190)156(267)217-119(59-67-141(250)251)163(274)214-115(55-63-135(192)242)159(270)215-116-56-64-137(244)237-238-138(245)84-130(221-151(262)103(23)203-150(261)102(22)204-152(116)263)174(285)228-129(83-136(193)243)173(284)212-113(53-44-75-201-184(197)198)158(269)222-122(76-92(5)6)167(278)223-123(77-93(7)8)168(279)224-124(78-94(9)10)169(280)229-132(86-145(258)259)178(289)236-186(26,88-98(17)18)182(293)234-146(149(194)260)99(19)28-2/h32-34,45-46,89,91-103,107-133,146-148,239H,27-31,35-44,47-88,90,187-190H2,1-26H3,(H2,191,241)(H2,192,242)(H2,193,243)(H2,194,260)(H,199,202)(H,203,261)(H,204,263)(H,205,240)(H,206,264)(H,207,268)(H,208,272)(H,209,273)(H,210,275)(H,211,282)(H,212,284)(H,213,265)(H,214,274)(H,215,270)(H,216,266)(H,217,267)(H,218,271)(H,219,290)(H,220,291)(H,221,262)(H,222,269)(H,223,278)(H,224,279)(H,225,286)(H,226,287)(H,227,283)(H,228,285)(H,229,280)(H,230,281)(H,231,292)(H,232,276)(H,233,277)(H,234,293)(H,235,288)(H,236,289)(H,237,244)(H,238,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H,256,257)(H,258,259)(H4,195,196,200)(H4,197,198,201)/t99?,100?,101?,102-,103+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116-,117+,118+,119+,120+,121+,122+,123+,124+,125+,126+,127?,128+,129+,130+,131+,132+,133+,146+,147+,148+,185-,186-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 412 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of GST-tagged mTOR (1360 to 2549 residues) (unknown origin) using Ulight 4eBP1 peptide incubated for 90 mins by HTRF assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119610
(CHEMBL3618234)Show SMILES Cc1nc(N)nc(n1)-c1c(Nc2ccc3ncccc3c2)nc2ccccn12 Show InChI InChI=1S/C20H16N8/c1-12-23-18(27-20(21)24-12)17-19(26-16-6-2-3-10-28(16)17)25-14-7-8-15-13(11-14)5-4-9-22-15/h2-11,25H,1H3,(H2,21,23,24,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >780 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Search and Browse
